CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies
- PMID: 26316780
- PMCID: PMC4540135
- DOI: 10.2147/OTT.S85130
CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies
Abstract
The association between polymorphic CAG repeats in the androgen receptor gene in women and breast cancer susceptibility has been studied extensively. However, the conclusions regarding this relationship remain conflicting. The purpose of this meta-analysis was to identify whether androgen receptor CAG repeat lengths were related to breast cancer susceptibility. The MEDLINE, PubMed, and EMBASE databases were searched through to December 2014 to identify eligible studies. Data and study quality were rigorously assessed by two investigators according to the Newcastle-Ottawa Quality Assessment Scale. The publication bias was assessed by the Begg's test. Seventeen eligible studies were included in this meta-analysis. The overall analysis suggested no association between CAG polymorphisms and breast cancer risk (odds ratio [OR] 1.031, 95% confidence interval [CI] 0.855-1.245). However, in the subgroup analysis, we observed that long CAG repeats significantly increased the risk of breast cancer in the Caucasian population (OR 1.447, 95% CI 1.089-1.992). Additionally, the risk was significantly increased in Caucasian women carrying two alleles with CAG repeats ≥22 units compared with those with two shorter alleles (OR 1.315, 95% CI 1.014-1.707). These findings suggest that long CAG repeats increase the risk of breast cancer in Caucasian women. However, larger scale case-control studies are needed to validate our results.
Keywords: CAG repeat polymorphism; androgen; breast cancer; meta-analysis; risk; women.
Figures






Similar articles
-
The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.Cancer Res. 2002 Feb 15;62(4):1045-9. Cancer Res. 2002. PMID: 11861380
-
Association between androgen receptor polymorphic CAG and GGC repeat lengths and cryptorchidism: A meta-analysis of case-control studies.J Pediatr Urol. 2018 Oct;14(5):432.e1-432.e9. doi: 10.1016/j.jpurol.2018.05.011. Epub 2018 Jun 7. J Pediatr Urol. 2018. PMID: 29914823
-
Association between CAG repeat polymorphisms and the risk of prostate cancer: a meta-analysis by race, study design and the number of (CAG)n repeat polymorphisms.Int J Mol Med. 2013 Nov;32(5):1195-203. doi: 10.3892/ijmm.2013.1474. Epub 2013 Aug 23. Int J Mol Med. 2013. PMID: 23982466
-
Shorter GGN Repeats in Androgen Receptor Gene Would Not Increase the Risk of Prostate Cancer.Technol Cancer Res Treat. 2017 Apr;16(2):159-166. doi: 10.1177/1533034616673272. Epub 2016 Oct 17. Technol Cancer Res Treat. 2017. PMID: 28279145 Free PMC article. Review.
-
Impact of CAG repeat length in the androgen receptor gene on male infertility - a meta-analysis.Reprod Biomed Online. 2016 Jul;33(1):39-49. doi: 10.1016/j.rbmo.2016.03.012. Epub 2016 Apr 19. Reprod Biomed Online. 2016. PMID: 27157932 Review.
Cited by
-
Investigation of the role of X chromosome inactivation and androgen receptor CAG repeat polymorphisms in patients with recurrent pregnancy loss: a prospective case-control study.BMC Pregnancy Childbirth. 2022 Nov 2;22(1):805. doi: 10.1186/s12884-022-05113-z. BMC Pregnancy Childbirth. 2022. PMID: 36324098 Free PMC article.
-
Comparison of NGS panel and Sanger sequencing for genotyping CAG repeats in the AR gene.Mol Genet Genomic Med. 2020 Jun;8(6):e1207. doi: 10.1002/mgg3.1207. Epub 2020 Mar 25. Mol Genet Genomic Med. 2020. PMID: 32216057 Free PMC article.
-
The Other Side of the Coin: May Androgens Have a Role in Breast Cancer Risk?Int J Mol Sci. 2021 Dec 31;23(1):424. doi: 10.3390/ijms23010424. Int J Mol Sci. 2021. PMID: 35008851 Free PMC article. Review.
-
Lack of Androgen Receptor Expression Selects for Basal-Like Phenotype and Is a Predictor of Poor Clinical Outcome in Non-Metastatic Triple Negative Breast Cancer.Front Oncol. 2020 Jul 28;10:1083. doi: 10.3389/fonc.2020.01083. eCollection 2020. Front Oncol. 2020. PMID: 32850312 Free PMC article.
-
Variable number tandem repeats (VNTRs) as modifiers of breast cancer risk in carriers of BRCA1 185delAG.Eur J Hum Genet. 2023 Feb;31(2):216-222. doi: 10.1038/s41431-022-01238-z. Epub 2022 Nov 25. Eur J Hum Genet. 2023. PMID: 36434258 Free PMC article.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. - PubMed
-
- Giguere Y, Dewailly E, Brisson J, et al. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population. Cancer Res. 2001;61:5869–5874. - PubMed
-
- Given HF, Radbourne R, Oag H, et al. The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer. Eur J Cancer. 2000;36:533–534. - PubMed
-
- Dagan E, Friedman E, Paperna T, Carmi N, Gershoni-Baruch R. Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype. Eur J Hum Genet. 2002;10:724–728. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical